Dr. Mariele Briones, MD (she/her) is an Endocrinologist in West chester, PA with over 16 years of experience. What is your opinion of Dr. Mariele Briones, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mariele Briones, MD has received over $13,760 which includes payments from the following companies:
$1,426.63 from LILLY USA, LLC
$1,280.18 from Novo Nordisk Inc
$1,064.08 from Tandem Diabetes Care, Inc.
$1,033.20 from Amgen Inc.
$1,003.89 from AstraZeneca Pharmaceuticals LP
$877.93 from sanofi-aventis U.S. LLC
$563.24 from Boehringer Ingelheim Pharmaceuticals, Inc.
$514.11 from Dexcom, Inc.
$433.53 from Medtronic MiniMed, Inc.
$408.27 from AbbVie, Inc.
$392.42 from Janssen Pharmaceuticals, Inc
$375.45 from GlaxoSmithKline, LLC.
$314.25 from Amarin Pharma Inc.
$300.32 from Abbott Laboratories
$248.82 from Valeritas, Inc.
$235.61 from Gemini Laboratories, LLC
$225.88 from Becton, Dickinson and Company
$220.72 from INSULET CORPORATION
$204.17 from Takeda Pharmaceuticals America, Inc.
$183.29 from Pfizer Inc.
Payments received by Dr. Mariele Briones, MD were from the following categories:
$12,613.87 Food and Beverage
$1,050.22 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!